Big Bets, Delayed Gains – The Reality Behind India’s EMS Expansion
Large capex in components can improve margins long-term, but execution delays and global supply shocks impact near-term profitability.
A factory owner hears strong customer demand and decides to expand. New machines. Bigger capacity. Higher ambition.
That is what is happening in India’s EMS space.
Companies are investing hundreds and thousands of crores into PCBs, displays, camera modules, and semiconductor packaging. The idea is clear: control more of the value chain and earn better margins.
Syrma is building multilayer and single-layer PCB capacity with fresh capex. Dixon is investing heavily in displays and scaling camera modules. Kaynes is committing large sums to PCB and OSAT facilities. The expectation? Meaningful margin expansion by FY28.
But manufacturing is not instant.
Timelines move. Trials get delayed. Capacity ramp-up takes months. Joint ventures push out start dates. Every delay shifts the margin story forward.
At the same time, global shocks add pressure. Memory prices have surged as global suppliers prioritize AI-driven demand. That has squeezed smartphone manufacturers, impacting shipment volumes. When brands slow orders, EMS companies feel it immediately.
So the story has two sides:
Long term — deeper integration, stronger margins, bigger wallet share.
Short term — capex stress, execution risk, external supply disruptions.
Nifty 500 Stocks Linked to This Theme:
• Dixon Technologies (India) Ltd